Biomednewsbreaks - Annovis Bio Inc. (NYSE: ANVS) CEO To Present At Oppenheimer Healthcare Conference
Annovis Bio (NYSE: ANVS) a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced that CEO Maria M ...